Oxford Asset Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $144K | Sell |
2,911
-5,652
| -66% | -$280K | 0.02% | 127 |
|
|
2019
Q4 | $658K | Buy |
+8,563
| New | +$658K | 0.02% | 1092 |
|
|
2019
Q2 | – | Sell |
-4,852
| Closed | -$257K | – | 1724 |
|
|
2019
Q1 | $257K | Sell |
4,852
-1,326
| -21% | -$70.2K | 0.01% | 1441 |
|
|
2018
Q4 | $290K | Buy |
6,178
+2,104
| +52% | +$98.8K | 0.01% | 1415 |
|
|
2018
Q3 | $362K | Buy |
4,074
+1,820
| +81% | +$162K | 0.01% | 1432 |
|
|
2018
Q2 | $234K | Sell |
2,254
-1,558
| -41% | -$162K | ﹤0.01% | 1552 |
|
|
2018
Q1 | $305K | Buy |
3,812
+2,363
| +163% | +$189K | 0.01% | 1401 |
|
|
2017
Q4 | $196K | Buy |
1,449
+340
| +31% | +$46K | ﹤0.01% | 1460 |
|
|
2017
Q3 | $187K | Buy |
1,109
+453
| +69% | +$76.4K | ﹤0.01% | 1432 |
|
|
2017
Q2 | $98K | Buy |
+656
| New | +$98K | ﹤0.01% | 1412 |
|
|
2017
Q1 | – | Sell |
-641
| Closed | -$133K | – | 1396 |
|
|
2016
Q4 | $133K | Buy |
+641
| New | +$133K | ﹤0.01% | 723 |
|